Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis
Recruiting
Phase 4
Interventional Study
Peritoneal Dialysis-associated Peritonitis
Vitamin D Deficiency
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 176 (estimated)
- Sponsor
- Peking University First Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a multicenter randomized, placebo-controlled trial of Vitamin D supplementation in patients on peritoneal dialysis to determine whether oral administration of vitamin D3 after curing an episode of peritonitis could reduce the risk of subsequent peritoneal dialysis-related peritonitis.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Medically stable and receiving peritoneal dialysis for \> 1 month
* Older than 18 years old
* Serum 25(OH)D \< 30ng/ml
* Adequate dialysis on evaluation with weekly Kt/V ≥ 1.5, or (revised time: 2023-7-11) without clinical uremic symptoms
Exclusion Criteria:
* Receive Vitami…
Contacts